These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


337 related items for PubMed ID: 11440895

  • 1. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
    Hupfeld CJ, Weiss RH.
    Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E207-16. PubMed ID: 11440895
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC, Boehm M, Akyürek LM, San H, Yang ZY, Tashiro J, Nabel GJ, Nabel EG.
    Circulation; 2000 May 02; 101(17):2022-5. PubMed ID: 10790340
    [Abstract] [Full Text] [Related]

  • 3. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
    Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M.
    Hepatology; 2001 May 02; 33(5):1087-97. PubMed ID: 11343236
    [Abstract] [Full Text] [Related]

  • 4. Critical role of both p27KIP1 and p21CIP1/WAF1 in the antiproliferative effect of ZD1839 ('Iressa'), an epidermal growth factor receptor tyrosine kinase inhibitor, in head and neck squamous carcinoma cells.
    Di Gennaro E, Barbarino M, Bruzzese F, De Lorenzo S, Caraglia M, Abbruzzese A, Avallone A, Comella P, Caponigro F, Pepe S, Budillon A.
    J Cell Physiol; 2003 Apr 02; 195(1):139-50. PubMed ID: 12599217
    [Abstract] [Full Text] [Related]

  • 5. p21(Waf1/Cip1) is an assembly factor required for platelet-derived growth factor-induced vascular smooth muscle cell proliferation.
    Weiss RH, Joo A, Randour C.
    J Biol Chem; 2000 Apr 07; 275(14):10285-90. PubMed ID: 10744715
    [Abstract] [Full Text] [Related]

  • 6. Glucocorticoids stimulate p21(CIP1) in mesangial cells and in anti-GBM glomerulonephritis.
    Terada Y, Okado T, Inoshita S, Hanada S, Kuwahara M, Sasaki S, Yamamoto T, Marumo F.
    Kidney Int; 2001 May 07; 59(5):1706-16. PubMed ID: 11318941
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL.
    Cancer Res; 2002 Jun 01; 62(11):3126-31. PubMed ID: 12036924
    [Abstract] [Full Text] [Related]

  • 8. The permissive effect of p21(Waf1/Cip1) on DNA synthesis is dependent on cell type: effect is absent in p53-inactive cells.
    Weiss RH, Randour CJ.
    Cell Signal; 2000 Jun 01; 12(6):413-8. PubMed ID: 10889470
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL, Hsu JW, Liu MC, Chen LY, Chang CD.
    Exp Cell Res; 2000 Aug 01; 258(2):322-31. PubMed ID: 10896783
    [Abstract] [Full Text] [Related]

  • 13. Tranilast inhibits vascular smooth muscle cell growth and intimal hyperplasia by induction of p21(waf1/cip1/sdi1) and p53.
    Takahashi A, Taniguchi T, Ishikawa Y, Yokoyama M.
    Circ Res; 1999 Mar 19; 84(5):543-50. PubMed ID: 10082476
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of lovastatin on expression of cell cycle regulatory proteins in vascular smooth muscle cells.
    Oda H, Kasiske BL, O'Donnell MP, Keane WF.
    Kidney Int Suppl; 1999 Jul 19; 71():S202-5. PubMed ID: 10412776
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1).
    Marra DE, Simoncini T, Liao JK.
    Circulation; 2000 Oct 24; 102(17):2124-30. PubMed ID: 11044431
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.